Braze (BRZE) just posted its Q1 2027 numbers, reporting revenue of US$211.0 million and a basic EPS loss of US$0.24, with net income excluding extra items showing a loss of US$26.6 million. The company has seen quarterly revenue move from US$162.1 million in Q1 2026 through US$205.2 million in Q4 2026 to US$211.0 million in Q1 2027. Over the same stretch, basic EPS went from a loss of US$0.34 to a loss of US$0.29 and then a loss of US$0.24, which may lead investors to focus on how efficiently that top line is being converted as margins evolve.

See our full analysis for Braze.

With the headline figures on the table, the next step is to see how this mix of revenue growth and ongoing losses lines up with the key narratives that have been building around Braze over the past year.

Revenue Near US$211 million, Losses Still Heavy

• On a trailing twelve month basis Braze recorded revenue of US$787.1 million and a net loss of US$122.1 million, compared with quarterly Q1 2027 revenue of US$211.0 million and a net loss of US$26.6 million excluding extra items.
• Bulls argue that revenue momentum can underpin a path to healthier margins, and the current figures partly align with that idea, but they also show the work still to be done:
  • The bullish narrative points to annual revenue growth of about 19.6% over the next three years, while the latest data shows trailing revenue at US$787.1 million versus Q1 revenue of US$211.0 million, which keeps the focus firmly on scaling the top line.
  • At the same time, the trailing loss of US$122.1 million and the Q1 2027 loss of US$26.6 million mean profitability is not yet in sight, so the bullish case leans heavily on future margin improvement rather than what is visible in these results.

Braze’s latest numbers give bulls plenty to point to on growth, but the sizeable losses mean the optimistic thesis is still mainly about what could change in future rather than what has already shown up in the income statement. 🐂 Braze Bull Case

Persistent Loss Trend Tests Bear Concerns

• Over the last five reported quarters, quarterly net loss excluding extra items ranged from US$35.8 million in Q1 2026 to US$26.6 million in Q1 2027, while trailing twelve month net loss moved from US$103.9 million in Q1 2026 to US$122.1 million in Q1 2027.
• Bears focus on ongoing unprofitability and rising losses over time, and the data gives them support but also some nuance:
  • The risk summary notes that losses have grown at about 9.9% per year over five years and are forecast to continue for at least three more years, and the trailing loss of US$122.1 million is higher than the US$103.9 million recorded a year earlier, which is consistent with that concern.
  • However, within the last year individual quarterly losses have ranged between about US$26.6 million and US$36.0 million, so while the longer term trend points to larger losses, the most recent few quarters do not show a simple one way move, which means bears are still watching to see if cost trends stabilize or not.

Skeptics who worry about the loss profile can point to a larger trailing twelve month loss year on year, but the quarter by quarter pattern is a bit more mixed than the headline five year trend suggests. 🐻 Braze Bear Case

Valuation Gap Versus US$23.36 Share Price

• At a share price of US$23.36 and a P/S of 3.3x versus a peer average of 7.1x and US Software at 3.8x, Braze is also referenced as trading below a DCF fair value of about US$49.09 and below a single allowed analyst target of US$34.40.
• Supporters of the bullish and consensus narratives highlight this gap as part of the upside case, while the risk data reminds readers why the discount exists:
  • Revenue is forecast to grow about 13.4% a year, which is above the 11.9% rate cited for the US market, so the lower P/S multiple and the spread between US$23.36 and the DCF fair value of roughly US$49.09 are often viewed as a potential opportunity if that growth continues.
  • On the other hand, forecasts still show no profitability for at least three years and there has been significant insider selling in the last three months, which helps explain why the market is not pricing Braze closer to the US$34.40 analyst target or the DCF fair value despite the revenue outlook.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Braze on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With both risks and rewards in play, you have a fairly balanced picture to work with. It makes sense to check the data yourself, decide how it fits your goals, and then weigh 3 key rewards and 2 important warning signs

See What Else Is Out There

Braze is still reporting sizeable losses alongside revenue growth, with profitability not yet in sight and insider selling adding another concern for cautious investors.

If you want ideas where the focus is more on strong fundamentals and less on ongoing losses, it is worth checking out the solid balance sheet and fundamentals stocks screener (46 results) today to compare alternatives that may better fit a lower risk profile.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.